Top 50 Medical Startup Investors in Australia in May 2026
Top 50 Medical Startup Investors in Australia in May 2026
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
- NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Software, Artificial Intelligence, Health Care
- Seed, Pre-Seed, Series A
- Australia, United States, Hong Kong
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- CLIQ — We understand firsthand the impact of social isolation and the longing for genuine human connection. CLIQ was born from a vision to address this issue and to fundamentally transform the way that we meet new people and form connections.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Biotechnology, Health Care, Manufacturing
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
- VeriQuantix — VeriQuantix was spun out of the University of Queensland. VeriQuantix is an Australian startup specializing in cybersecurity, focusing on quantum technology to enhance the security of optical fiber communication networks. Their core innovation, Quantum Link Verification (QLV), is designed to detect and alert network operators to physical tappingattempts and intercept cyber attacks on fiber optic networks. This technology leverages quantum principles, specifically entangled photons, to verify the trustworthiness of network links by ensuring that any unauthorized access disrupts photon entanglement and triggers immediate alerts.
- Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Biotechnology, Health Care, Manufacturing
- Series A, Seed, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more...Investment focus
- Health Care, Software, Information Technology
- Seed, Series A, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- Indi — indi is an assistant for your child's care journey; supporting advocacy, mental health & uniting the village of care.
- Great Wrap — The only Australian made and owned compostable cling wrap
- Conserving Beauty — Acne Care Reimagined. Skincare formulated for for acne-prone and sensitive skin. Clinically tested and shown to cause no dermal irritation or sensitization. Australian and STEM Female Founded.
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more...Investment focus
- Software, Artificial Intelligence, Manufacturing
- Seed, Series A, Series B
- Australia, United States, Philippines
Portfolio highlights
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
- Prospection — Helping pharmaceutical brand teams unlock patient-centric intelligence to drive better patient care outcomes and capture market share opportunities.
- QuintessenceLabs — Quantum cyberattacks can break current encryption in minutes! Get protected with QuintessenceLabs quantum key distribution, generation, and management.
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more...Investment focus
- Biotechnology, Medical, Health Care
- Seed, Funding Round, Series A
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Lenexa Medical — Lenexa Medical is an Australian based MedTech company.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Software, Artificial Intelligence, Information Technology
- Pre-Seed, Seed, Series A
- Singapore, Australia, United Kingdom
Portfolio highlights
- Synthium — Synthium offers Cognition-as-a-Service (CaaS) for consumer robotics, using gamified web-based simulations to crowdsource human cognitive data for training robot AI models. Users engage in robotics tasks like spatial navigation via webcam and microphone inputs, generating diverse datasets for model training across robot types such as humanoids anddrones. Data captures human intuition in dynamic environments, enabling scalable AI development without physical robots.
- Alchemyst AI — Alchemyst AI is an innovative generative AI software-as-a-service (SaaS) startup that leverages cutting-edge artificial intelligence technology to deliver unique solutions tailored to various industries. Alchemyst aims to empower businesses to harness the potential of generative AI for enhanced creativity, efficiency, and decision-making.We arebuilding force multipliers within teams across various verticals - starting with Maya, our first Alchemyst for Sales Development. We would soon be horizontally scaling to other roles as well, integrating into wherever you work.Since inception, we have taken a bottom-up approach to building our platform as opposed to a top-down approach usually seen in SaaS products - keeping the client experience first.
- Cooper Pet Care — Just Russel honden- en kattenvoeding op maat. Op basis van ras, leeftijd, gezondheid en gewicht. Makkelijker voor jou, beter voor je huisdier!
EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.
Show more...Investment focus
- Software, SaaS, Information Technology
- Series A, Seed, Funding Round
- Australia, New Zealand, United States
Portfolio highlights
- Blend AI — Making online advertising easy for everyone. Blend connects to your store helping you measure the impact your ads are having on revenue.
- Mutiny — Mutiny is an analytics platform for marketing investments with a sizable customer base.
- Fergus — Fergus is a smart field service management software for service businesses. Make job management easy and carry out work better with our all-in-one solution.
Right Click Capital - Australian Venture Capital Firm
Show more...Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- Australia, Singapore, United States
Portfolio highlights
- black.ai — Build smarter spaces with Black.ai
- Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
- Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more...Investment focus
- SaaS, Software, Health Care
- Seed, Pre-Seed, Series A
- Australia, United States
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- Kapiche — Customer intelligence for CX, support and product teams who need to understand their customers accross more than just surveys. Analyze 100% of customer conversations to prevent churn and accelerate growth.
- Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Kurt Alexander
Show more...Investment focus
- Mining, Retail, Medical
- Seed, Funding Round
- Australia
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.
Show more...Investment focus
- Medical, Facial Recognition, Artificial Intelligence
- Seed, Funding Round
- Australia
Portfolio highlights
- Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.
Show more...Investment focus
- Software, Construction, SaaS
- Funding Round, Seed, Convertible Note
- Australia, United States
Portfolio highlights
- SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
- APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.
Show more...Investment focus
- EdTech, Medical, Education
- Seed
- Australia
Portfolio highlights
- PlanCare — Plan Care is a technology platform that helps participants via dedicated plan managers by providing guidance and responding to queries.
- My Mirror — Find the right online psychologist in Australia, tailored to your needs and schedule. Start online therapy today with no wait times. Book now, pay later
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Biotechnology, Artificial Intelligence, Software
- Series A, Series B, Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
- Fano Labs — We are one of the leading AI companies specialising on Language AI technologies for enterprises in customer services, compliance and other lines of businesses.
- Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Software, SaaS, Health Care
- Seed, Angel, Series A
- Australia, United States
Portfolio highlights
- Okkular — Okkular is an AI based fashion tech startup.
- iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more...Investment focus
- Software, Artificial Intelligence, SaaS
- Seed, Series A, Pre-Seed
- Australia, United States, New Zealand
Portfolio highlights
- Syenta — Syenta is transforming the electronics manufacturing sector. Our patented fabrication method enables the 3D printing of multi-material electronics with fewer steps and less waste.
- Blinq — Blinq makes it easy to share your contact details via QR code scanning on the mobile app.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more...Investment focus
- Software, Apps, EdTech
- Seed, Series A, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- Sphere — Live courses led by vetted experts for professionals who want to advance their careers
- Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
- Visionary Machines — Superior perception for next-generation autonomy
Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.
Show more...Investment focus
- Software, E-Commerce, Health Care
- Seed, Series A, Funding Round
- Australia, United States
Portfolio highlights
- OpusXenta — Byond is comprehensive business management software for cemeteries & crematoria, streamlining operations with mapping, record-keeping, sales management and more.
- PaidRight — Know your payroll compliance. Monitor variances in your payroll, get insights and visibility into your own payroll systems and processes so your employees are paid right.
- FLK It Over — Sign documents online easily with FLK it over. Get started with our electronic signature software in just 2 minutes with our 14-day free trial. Try it now!
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Show more...Investment focus
- Software, Financial Services, FinTech
- Seed, Series A, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Qlarifi — Consumer lending decisions transformed with real time, comprehensive data.
- Safewill — Safewill is Australia's leading online Will writing platform. With thousands of users, Safewill makes it easy and affordable to write your own legally binding will
- Ajust — Ajust makes it easy to resolve customer complaints with banks, telcos and energy companies. It's fast, fair and free for consumers.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Software, Financial Services, FinTech
- Funding Round, Series B, Convertible Note
- Australia, United States, United Kingdom
Portfolio highlights
- Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
- Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
- Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more...Investment focus
- Medical, Health Care, Medical Device
- Seed, Series A
- Australia
Portfolio highlights
- personr — Single source of truth for AML compliance
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
- VitalTrace — VitalTrace develops advanced biosensor technology to support safer childbirth. Our real-time fetal monitoring system helps detect distress during labour, empowering clinicians with data-driven decisions for better outcomes.
Larsen Ventures is a lean, driven and strategic venture investment firmWe believe in alignment, long-term thinking & investor due diligence We like metrics, traction & perseverance We invest in people 1/3 of our focus is on Health and Education; We like the thematic & overall gains for society2/3 of our time is spentlearning from peers, digging into research, chasing leads & hanging out on caffeinated zooms in the endless search for;Founders with Traction Founders with Insight Founders with Perseverance and Courage Founders with an innate ability to question EverythingWe have patient capital that engages & contributes to your Journey Accelerate your business with our portfolios' intellectual capital
Show more...Investment focus
- Software, Education, SaaS
- Seed, Series A, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Vitruvian Form — Vitruvian manufactures a connected fitness hardware, develops software and fitness class content.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Health Care, Manufacturing, Software
- Funding Round, Series A, Seed
- Australia, United States, Philippines
Portfolio highlights
- EntroMat — EntroMat is a pioneering deep-tech startup transforming the metal powder industry through the advancement of high entropy material (HEM) powders.
- Fyton Bio — FytonBio is a privately held, preclinical-stage biopharmaceutical company specializing in biotechnology research. Their core mission is to achieve functional cures for autoimmune and inflammatory diseases by deleting pathogenic immune cells. The company focuses on developing monoclonal antibodies capable of highly specific depletion of such cellsto durably alter disease progression.
- Myostellar — Myostellar is creating a first-in-class, highly differentiated biologic therapy that stimulates muscle stem cells to promote muscle regeneration with no fibrosis.
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more...Investment focus
- Software, Enterprise Software, Internet
- Series A, Series B, Funding Round
- United States, Australia, Philippines
Portfolio highlights
- Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,328,201 freelance designers compete to create amazing designs for your business. Start Today!
- Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.
Show more...Investment focus
- Events, Sports, Cycling
- Pre-Seed
- Hong Kong
Portfolio highlights
- GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
- VueMotion Labs — Optimize athletic performance with VueMotion's AI-driven movement analysis. Accessible, affordable, and trusted by pro teams worldwide. Start testing today!
- Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Archangel is an early stage venture capital fund based in Australia. We work with great founders and investors to build game changing companies together.
Show more...Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Pre-Seed, Series A
- Australia, United States, Philippines
Portfolio highlights
- GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Termina — Termina operates as an energy tech startup.
Black Sheep Capital is making its mark as a preferred investment capital provider due to their 'Everyone Wins' approach. Their philosophy is to work with their investment partners to create and grow opportunities where they can all enjoy success. Through this approach, they have been able to create a diverse portfolio of investments thatcontinues to grow.
Show more...Investment focus
- Software, Internet, E-Commerce
- Seed, Series A, Series C
- Australia, United States
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Kleecks — Kleecks is an innovative SaaS platform that optimises performance marketing activities, improves website health and speed in real-time, and has a significant impact on businesses by increasing revenues, lowering costs, and accelerating time-to-market
- Project Manda — Transform your workspace with Project Manda's AI-driven platform. Analyse company meetings, receive actionable recommendations, and boost staff productivity and ROI
OIF is a venture capital firm focusing on partnering with entrepreneurs building businesses.
Show more...Investment focus
- Software, SaaS, Internet
- Series A, Seed, Funding Round
- Australia, United States, Brazil
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Nullify — Nullify performs product security tasks alongside your developers.
- LoveHeart — LoveHeart is an AI educator-aide that streamlines child development documentation. Write learning stories, journals, plans, and reflections in seconds. Trusted by leading educators. Get your team plan today.
Prtnr is an investment firm.
Show more...Investment focus
- Medical, Hospital, Health Care
- Seed
- Australia
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
Salus Ventures is a venture capital firm.
Show more...Investment focus
- Organic, Robotics, Aerospace
- Seed, Series A
- Australia
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Q-CTRL — Infrastructure software to power the quantum future
- ExoFlare — ExoFlare is built for intensive agri industries, transforming biosecurity from a compliance burden into a strategic advantage. Streamline and protect operations. Maintain market and capital access. Stay in business during incursions. Thrive amid escalating biosecurity risks.
Watermark Funds Management. A specialist long/short investor offering attractive returns while hedging share market risks.
Show more...Investment focus
- Medical, Software, Health Care
- Series A
- Australia
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
With origins in owning and operating Australian pharmacies, Soul Patts has evolved into a diversified investment house investing across a range of industries and asset classes, including listed equities, private equity, credit, and property.
Show more...Investment focus
- Software, Hotel, Men's
- Funding Round, Series A
- Australia
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
- InStitchu — InStitchu is an online custom clothier specializing in tailor made menswear. Customers are able to design custom made garments online which are then made to their exact measurements.InStitchu provides tailor made, high quality menswear through a simple online ordering process. Once a customer has added measurements to their profile, a suit orshirt can be ordered in a few minutes and on its way in two weeks. There are multiple ways for a customer to get their measurements perfected and enjoy that “perfect fit” InStitchu customers keep coming back for - our measurement guide will take you on a journey from your living room to the hustle and bustle of our tailor’s studio. Customers can choose from a wide range of globally sourced high quality wool and cotton fabrics, and when you’ve chosen, we’ll deliver your design right to your door. This new approach to shopping is stress free and cuts out the middleman, allowing us to deliver customers luxury tailor made suits and shirts without the high price tag.
- SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
Scalare Partners is more than a technology investment fund. We provide critical funding and resourcing
Show more...Investment focus
- Software, FinTech, Information Technology
- Seed, Pre-Seed, Funding Round
- Australia, Singapore, United States
Portfolio highlights
- Brauz — Brauz connects your customers now with Reserve In Store, Find in Store, Click + Collect, On Demand Delivery, Ship from Store, Appointment Booking, Video Commerce, Clienteling and more.
- Betterx — Betterx is a technology company focused on infrastructure to support Web3.0 and Digital Assets.
- Amelio Health — Amelio Health is a program integrating a set of pathways developing the capabilities of case managers to signpost claimants at risk of developing chronic pain
Stephen Baxter - Founder @ River City Labs
Show more...Investment focus
- Software, SaaS, Health Care
- Seed, Pre-Seed, Angel
- Australia, United States
Portfolio highlights
- DoseMe — Quick, simple & easy dosing calculator. With DoseMeRx in your EHR, save time & predict the optimal dose of medications with just one blood sample.
- OrionVM — OrionVM is a Wholesale Cloud Infrastructure-as-a-Service (IaaS) company that has developed a revolutionary technology suite (virtual storage, compute, orchestration and virtual networking) to enable the delivery of high performing, highly reliable cloud solutions at market leading price-to-performance ratios. Groundbreaking engineering supportsPublic, Hybrid and Private Cloud deployments and offers an agile system for internal consumption or resale. OrionVM’s Wholesale Cloud Platform provides the best margins, superior performance, and increased technical reliability for resellers and wholesalers of cloud services. OrionVM’s head office is in Sydney, Australia, with U.S. offices also in the San Francisco Bay Area.
- Car Next Door — Hire a car, van or ute from our community of local car owners, or rent out your car and make extra money. Peer-to-peer car share in Sydney, Melbourne, Newcastle.
QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Series A
- Australia
Portfolio highlights
- Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
- Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Change the tagline
Show more...Investment focus
- Software, Internet, Financial Services
- Funding Round, Seed, Series C
- Australia, United States
Portfolio highlights
- Carbar — Buy, finance or subscribe to your next car online. Sell your car without haggling, get an instant valuation.
- InStitchu — InStitchu is an online custom clothier specializing in tailor made menswear. Customers are able to design custom made garments online which are then made to their exact measurements.InStitchu provides tailor made, high quality menswear through a simple online ordering process. Once a customer has added measurements to their profile, a suit orshirt can be ordered in a few minutes and on its way in two weeks. There are multiple ways for a customer to get their measurements perfected and enjoy that “perfect fit” InStitchu customers keep coming back for - our measurement guide will take you on a journey from your living room to the hustle and bustle of our tailor’s studio. Customers can choose from a wide range of globally sourced high quality wool and cotton fabrics, and when you’ve chosen, we’ll deliver your design right to your door. This new approach to shopping is stress free and cuts out the middleman, allowing us to deliver customers luxury tailor made suits and shirts without the high price tag.
- CarExpert.com.au — Australia's most reputable and independent motoring experts bring you the latest car reviews, comparisons, news and auto content.
The CP Ventures Fund invests in early-stage technology companies that are highly scalable, at the forefront of breakthrough technologies, and driven by the fourth industrial revolution.
Show more...Investment focus
- Software, Artificial Intelligence, Machine Learning
- Seed, Pre-Seed, Funding Round
- Australia, United States, India
Portfolio highlights
- LeadStory — Watch breaking news from around the world and stay up to date with current events. Follow topics that matter to you from providers you can trust. See whats happening nearby or in places you care about.
- Greenfly — Greenfly's short-form media orchestration software platform captures, collects, organizes & distributes videos & photos to drive fan engagement and boost revenue for sports and entertainment organizations.
- Skylark Labs — Skylark Labs develops continuously evolving and customizable threat detection systems for enhanced physical security. Our clients (CCTV or Drone companies) can customize our proprietary AI solutions at the time of deployment or continuously evolve them if needed after deployment making them preferable to other comparable market solutions.
Mr. Li Ka-shing is the richest person of East Asian descent in the world and the 11th richest person in the world with an estimated wealth of US$26 billion (as estimated by Forbes). His primary operating company is Hutchison Whampoa Limited. Mr Li's younger son, Richard, is Chairman of PCCW, one of Asia's leading internet andtelecommunications companies.Mr Li Ka-shing is the Chairman of Cheung Kong (Holdings) Limited and Hutchison Whampoa Limited. Cheung Kong (Holdings) Limited is the flagship of the Cheung Kong Group which has business operations in 54 countries around the world and employs about 240,000 staff. In Hong Kong alone, the Group includes nine listed companies with a combined market capitalization of approximately HKD600 billion (30 June 2009). Hutchison Whampoa Limited is a Fortune Global 500 company.Born in 1928 in Chiu Chow, a coastal city in the southeastern part of China, Mr Li fled to Hong Kong with his family to avoid the perils of war. His father suffered from tuberculosis and passed away in Hong Kong. Shouldering the responsibility of looking after the livelihood of the family, Mr Li was forced to leave school before the age of 15 and found a job in a plastics trading company where he labored 16 hours a day. By 1950, his hard work, prudence and his pursuit of excellence had enabled him to start his own company, Cheung Kong Industries. From manufacturing plastics, Mr Li led and developed his company into a leading real estate investment company in Hong Kong that was listed on the Hong Kong Stock Exchange in 1972. Cheung Kong continued to expand by acquiring Hutchison Whampoa and Hongkong Electric Holdings Limited in 1979 and 1985 respectively.Based in Hong Kong, the Cheung Kong Group's businesses encompass such diverse areas as property development and investment, real estate agency and estate management, hotels, telecommunications and e-commerce, finance and investments, retail, ports and related services, energy, infrastructure projects and materials, media, and biotechnology. Mr Li is a strong believer in synergy — the power of combined efforts. This belief is reflected in his naming his company Cheung Kong Holdings after the Yangtze River that flows through China, a great river that aggregates countless streams and tributaries. The Times in the United Kingdom and Ernst & Young UK jointly named Mr Li as the Entrepreneur of the Millennium at the turn of the century.http://www.hutchison-whampoa.com/eng/about/chairman/chairman.htm 30 June 2009
Show more...Investment focus
- Health Care, Biotechnology, Food and Beverage
- Series A, Series B, Seed
- United States, United Kingdom, Israel
Portfolio highlights
- H2Pro — H2Pro is a renewable energy company that is working on an efficient green hydrogen production method - E-TAC. Its mission is to enable the wide-scale adoption of sustainable hydrogen fuel by introducing a novel water-splitting technology.
- Omni — Omni aims to revolutionise mobility in cities and campuses by empowering residents with cleaner, more efficient, and affordable transportation options that improve urban sustainability in the United Kingdom. By systematically deploying thousands of smart-bikes, enabled with GPS, wireless technology, and self-locks, we will dramatically improveurban mobility by making the first and last mile faster, cheaper, and healthier. We take city and school friendly approach and seek for partnership to work on this challenging problem.
- Fertilis — Fertilis: A better way to care for your embryos in an IVF clinic. Fertilis technology involves each embryo growing inside its own patented micro-3D printed pod. The pod protects the embryo and enables automated subtle changes to the nutritive composition of the solutions that bathe the embryo.
Pollenizer is a co-founder of start-up web businesses in Australia. They partner with strong founders and take equity stakes at a concept stage on consumer and SaaS businesses. The skill sets cover technology, marketing and capital raising. They also occasionally make seed investments. Their businesses include;* * ** * * * * * * * * * Their team includes;* Phil Morle, ex-CTO of Kazaa, Omnidrive.* Mick Liubinskas, ex-CMO of Kazaa, Tangler, ZaprThey are also investors and partners with
Show more...Investment focus
- B2B, E-Commerce, Marketplace
- Seed, Angel, Funding Round
- Australia
Portfolio highlights
- LawPath — Create legal documents, manage compliance and connect with lawyers on demand. Less stress, more time and better business. Sign up for free.
- CohortIQ — cohortiQ Home Page
- HiveXchange — Designed and built in Australia for the fresh produce industry. Find opportunities, create private offers, make product requests, get notified of deals in real time. Trade easy.
Luke & Janelle Roberts
Show more...Investment focus
- Mining, Retail, Medical
- Seed
- Australia
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Donald Kirk
Show more...Investment focus
- Mining, Retail, Medical
- Seed
- Australia
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Andrew R Banks
Show more...Investment focus
- Grocery, Medical, Health Care
- Seed
- Australia
Portfolio highlights
- Deliciou — Plant-based meat, seasonings, spices and condiments. Free worldwide shipping.
- Osara Health — We empower people and organisations affected by cancer to thrive with our expertise, empathy and technology.
Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.
Show more...Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Series C
- United States, United Kingdom, Canada
Portfolio highlights
- Vizgen — Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and detection efficiency at subcellular resolution. The highthroughput and resolution and the low cost per cell achieved by the technology will enable a wide range of tissue-scale basic research and development and will be instrumental to efforts to discover and map cell types and states in a range of tissues and organisms.
- Octave — Octave Bioscience is an early-stage molecular diagnostics company focused on neurodegenerative diseases and conditions. The company was co-founded by Melinda Thomas and William Hagstrom in 2013. Octave Bioscience is headquartered in Menlo Park, California, United States.
- Elephas — Elephas is a live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug development.
Titanium Ventures is the results-oriented VC partner to the most promising technology startups. Accelerating extraordinary companies and fueling growth of standout disruptors.
Show more...Investment focus
- Software, Information Technology, Artificial Intelligence
- Series B, Series C, Series A
- United States, China, Australia
Portfolio highlights
- Qiniu — Qiniu Cloud is a leading enterprise cloud service provider in China. It is committed to driving social industry development with cloud technology, and it focuses on the cloud computing industry with data intelligence and visual intelligence as its core. Through massive data and rich media scenarios across industries, Qiniu Cloud launches theintelligent video cloud integrated with CDN, object storage, cloud host, big data, content recognition platform and other product portfolios, which provides comprehensive cloud computing service for users. More than one million enterprise-level clients are using qiniu cloud to provide services for 80% of the Internet users nationwide. It provides cloud plus smart technology empowerment for users in various industries to meet the new opportunities of Artificial Intelligence and the arrival of 5G era.
- Hypereal — Hypereal is a virtual reality technology company. It is the only VR company in China that has its own software ecosystem, VR headsets, positioning tracking system, interactive controllers, SDK, and game team. As a leading Chinese VR/AR technology company, their products are conceived and made in China.
- OpenSolar — OpenSolar connects homeowners, solar professionals, and partners with free software to design, sell, and manage fast, accurate solar projects.
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more...Investment focus
- Biotechnology, Information Technology, Internet
- Angel, Seed, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- Insite AI — The chosen partner by executives in RGM, insights, and I.T. to grow revenue and market share. Learn how CPGs win in pricing, assortment, trade and more.
- Seitec — Seitec is a security company that manufactures seismic security applications and instruments for civilian and military markets.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
Catherine Lacavera is the Chief Legal Officer of ShipBob. She previously worked at Color Health as a Chief Legal Officer. Catherine Lacavera attended the University of Toronto.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Seed, Pre-Seed
- Canada, Australia
Portfolio highlights
- Skritswap — skritswap has AI technology that enables anyone to understand anything regardless of complexity.
- HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
Thorney Opportunities Ltd is an investment company. The Company's principal activity is making investments in listed securities. The Company is focused on producing absolute returns for shareholders over the medium to long-term. Its primary focus is on the selection of investments, which enable it to be a catalyst towards unlocking the valuein the companies that it identifies. The Company's investment manager is Thorney Management Services Pty Ltd.
Show more...Investment focus
- Software, Internet, Financial Services
- Series A, Funding Round, Series B
- Australia, United States, Israel
Portfolio highlights
- Dubber — The Dubber Platform provides call recording and audio asset management in the cloud.Dubber is a transformative Cloud-based Software-as-a-Service (SaaS) solution in a multi-billion dollar hardware-centric marketplace. It provides enhanced service and is flexible to a myriad of requirements not easily achievable with current market solutions.TheDubber Platform: • Captures call recordings from many sources including from browsers, mobile, private automatic branch exchange (PABX), hosted voice applications and legacy recording devices. • Manages recordings in a secure, permission-based environment. Call recordings are immediately searchable and accessible from any location via a web browser. Dubber has market-leading scalability both in terms of concurrent recording and storage. • Provides value-added tools enabling the use of recordings to enhance existing business systems and processes. A recording will be available across all devices and is instantly accessible for many and varied User requirements. The Dubber Platform is a Native Cloud product delivering secure, scalable and robust functionality at a significant saving compared to the cost base normally associated with traditional call recording offerings. Dubber is a classic transformation of a traditional hardware/software market to a Cloud-based platform and delivers many competitive advantages.
- Willed — Write your Will and Powers of Attorney online with Willed. Get help with Probate, arrange a funeral service, direct cremation or prepaid funeral plan.
- BabyQuip — Rent baby equipment for holidays and vacation. All the baby gear and furniture you need: cribs, strollers, car seats, toys, etc. We deliver, setup and pick-up.
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!